User menu

wbMRI to detect bone metastases: critical review on diagnostic accuracy and comparison to other imaging modalities

Bibliographic reference Pasoglou, Vasiliki ; Michoux, Nicolas ; Tombal, Bertrand ; Jamar, François ; Lecouvet, Frédéric. wbMRI to detect bone metastases: critical review on diagnostic accuracy and comparison to other imaging modalities. In: Clinical and Translational Imaging, Vol. 3, no.2, p. 141-157 (2015)
Permanent URL http://hdl.handle.net/2078.1/186655
  1. Padhani AHJ (1998) Imaging in oncology/bone metastases. Isis Medical Media, Oxford, pp 765–787
  2. Bronner F (2009) Bone and cancer. Springer, London
  3. Schirrmeister H, Guhlmann A, Kotzerke J et al (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17:2381–2389
  4. Even-Sapir E, Metser U, Mishani E et al (2006) The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 47:287–297
  5. Savelli G, Maffioli L, Maccauro M et al (2001) Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Q J Nucl Med 45:27–37
  6. Clinical PET and PET/CT, ISBN:9781441908018, 10.1007/978-1-4419-0802-5
  7. Walker R., Kessar P., Blanchard R., Dimasi M., Harper K., DeCarvalho V., Yucel E.K., Patriquin L., Eustace S., Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience, 10.1002/(sici)1522-2586(200004)11:4<343::aid-jmri1>3.0.co;2-p
  8. Lauenstein Thomas C., Freudenberg Lutz S., Goehde Susanne C., Ruehm Stefan G., Goyen Mathias, Bosk Silke, Debatin Jörg F., Barkhausen Jörg, Whole-body MRI using a rolling table platform for the detection of bone metastases, 10.1007/s00330-002-1344-z
  9. Lecouvet Frédéric E., Geukens Daphné, Stainier Annabelle, Jamar François, Jamart Jacques, d'Othée Bertrand Janne, Therasse Patrick, Berg Bruno Vande, Tombal Bertrand, Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies, 10.1200/jco.2006.09.2940
  10. Freedman Gary M, Negendank William G, Hudes Gary R, Shaer Andrew H, Hanks Gerald E, Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer, 10.1016/s0090-4295(99)00090-4
  11. Ghanem Nadir, Altehoefer Carsten, Högerle Stefan, Schäfer Oliver, Winterer Jan, Moser Ernst, Langer Mathias, Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton, 10.1016/s0720-048x(01)00477-6
  12. Engelhard K., Hollenbach H. P., Wohlfart K., von Imhoff E., Fellner F. A., Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer, 10.1007/s00330-003-1968-7
  13. NAKANISHI Katsuyuki, KOBAYASHI Midori, NAKAGUCHI Kazunori, KYAKUNO Miyaji, HASHIMOTO Nobuyuki, ONISHI Hiromitsu, MAEDA Noboru, NAKATA Saki, KUWABARA Masatomo, MURAKAMI Takamichi, NAKAMURA Hironobu, Whole-body MRI for Detecting Metastatic Bone Tumor: Diagnostic Value of Diffusion-weighted Images, 10.2463/mrms.6.147
  14. Kwee Thomas C., Takahara Taro, Ochiai Reiji, Nievelstein Rutger A. J., Luijten Peter R., Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology, 10.1007/s00330-008-0968-z
  15. Pearce T, Philip S, Brown J, Koh D M, Burn P R, Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI, 10.1259/bjr/30649204
  16. Thoeny Harriet C., De Keyzer Frederik, Extracranial applications of diffusion-weighted magnetic resonance imaging, 10.1007/s00330-006-0547-0
  17. Müller M F, Prasad P, Siewert B, Nissenbaum M A, Raptopoulos V, Edelman R R, Abdominal diffusion mapping with use of a whole-body echo-planar system., 10.1148/radiology.190.2.8284402
  18. Müller M F, Prasad P V, Bimmler D, Kaiser A, Edelman R R, Functional imaging of the kidney by means of measurement of the apparent diffusion coefficient., 10.1148/radiology.193.3.7972811
  19. Hövels A.M., Heesakkers R.A.M., Adang E.M., Jager G.J., Strum S., Hoogeveen Y.L., Severens J.L., Barentsz J.O., The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis, 10.1016/j.crad.2007.05.022
  20. Lecouvet Frédéric E., El Mouedden Jawad, Collette Laurence, Coche Emmanuel, Danse Etienne, Jamar François, Machiels Jean-Pascal, Vande Berg Bruno, Omoumi Patrick, Tombal Bertrand, Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?, 10.1016/j.eururo.2012.02.020
  21. Pasoglou Vasiliki, Larbi Ahmed, Collette Laurence, Annet Laurence, Jamar François, Machiels Jean-Pascal, Michoux Nicolas, Berg Bruno C. Vande, Tombal Bertrand, Lecouvet Frederic E., One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all-in-one” imaging approach? : One Step TNM Staging of Prostate Cancer Using MRI, 10.1002/pros.22764
  22. Costelloe Colleen M., Kundra Vikas, Ma Jingfei, Chasen Beth A., Rohren Eric M., Bassett Roland L., Madewell John E., Fast dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study, 10.1002/jmri.22815
  23. Pasoglou Vasiliki, Michoux Nicolas, Peeters Frank, Larbi Ahmed, Tombal Bertrand, Selleslagh Tom, Omoumi Patrick, Vande Berg Bruno C., Lecouvet Frédéric E., Whole-Body 3D T1-weighted MR Imaging in Patients with Prostate Cancer: Feasibility and Evaluation in Screening for Metastatic Disease, 10.1148/radiol.14141242
  24. Takahara TIY, Yamashita T, Yasuda S, Nasu S, Van Cauteren M (2004) Diffusion weighted whole body imaging with backgraound body signal suppression (DWIBS): technical impovement using free breathing STIR and high resolution 3D display. Radiat Med 22:275–282
  25. Berlin Jesse A., Rennie Drummond, Measuring the Quality of Trials : The Quality of Quality Scales, 10.1001/jama.282.11.1083
  26. Greenland S (1994) Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 140:290–296
  27. Bossuyt Patrick M, Reitsma Johannes B, The STARD initiative, 10.1016/s0140-6736(03)12122-8
  28. Whiting Penny, Rutjes Anne WS, Reitsma Johannes B, Bossuyt Patrick MM, Kleijnen Jos, The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, 10.1186/1471-2288-3-25
  29. Antoch Gerald, Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology, 10.1001/jama.290.24.3199
  30. Balliu E., Boada M., Peláez I., Vilanova J.C., Barceló-Vidal C., Rubio A., Galofré P., Castro A., Pedraza S., Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases, 10.1016/j.crad.2010.07.002
  31. Daldrup-Link Heike E., Franzius Christiane, Link Thomas M., Laukamp Daniela, Sciuk Joachim, Jürgens Heribert, Schober Otmar, Rummeny Ernst J., Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young Adults : Comparison with Skeletal Scintigraphy and FDG PET, 10.2214/ajr.177.1.1770229
  32. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka J T, Melhem E R, Yucel E K, A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases., 10.2214/ajr.169.6.9393186
  33. Goo Hyun Woo, Choi Seong Hoon, Ghim Thad, Moon Hyung Nam, Seo Jong Jin, Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods, 10.1007/s00247-005-1459-x
  34. Gutzeit Andreas, Doert Aleksis, Froehlich Johannes M., Eckhardt Boris P., Meili Andreas, Scherr Patrick, Schmid Daniel T., Graf Nicole, von Weymarn Constantin A., Willemse Edwin M. M., Binkert Christoph A., Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma, 10.1007/s00256-009-0789-4
  35. Heusner Till-Alexander, Kuemmel Sherko, Koeninger Angela, Hamami Monia E., Hahn Steffen, Quinsten Anton, Bockisch Andreas, Forsting Michael, Lauenstein Thomas, Antoch Gerald, Stahl Alexander, Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging, 10.1007/s00259-010-1399-z
  36. Heusner Till, Gölitz Philipp, Hamami Monia, Eberhardt Wilfried, Esser Stefan, Forsting Michael, Bockisch Andreas, Antoch Gerald, “One-stop-shop” staging: Should we prefer FDG-PET/CT or MRI for the detection of bone metastases?, 10.1016/j.ejrad.2009.10.031
  37. Jouvet JC, Thomas L, Thomson V et al (2013) Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT: CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study. J Eur Acad Dermatol Venereol. doi: 10.1111/jdv.12078
  38. Kembhavi S.A., Rangarajan V., Shah S., Qureshi S., Arora B., Juvekar S., Laskar S., Vora T., Chinnaswamy G., Ramadwar M., Kurkure P., Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours, 10.1016/j.crad.2014.04.006
  39. Kumar Jyoti, Seith Ashu, Kumar Atin, Sharma Raju, Bakhshi Sameer, Kumar Rakesh, Agarwala Sandeep, Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT, 10.1007/s00247-008-0921-y
  40. Laurent Valérie, Trausch Grégory, Bruot Olivier, Olivier Pierre, Felblinger Jacques, Régent Denis, Comparative study of two whole-body imaging techniques in the case of melanoma metastases: Advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT, 10.1016/j.ejrad.2009.04.059
  41. Ohno Yoshiharu, Koyama Hisanobu, Nogami Munenobu, Takenaka Daisuke, Yoshikawa Takeshi, Yoshimura Masahiro, Kotani Yoshikazu, Nishimura Yoshihiro, Higashino Takanori, Sugimura Kazuro, Whole-body MR imaging vs. FDG-PET: Comparison of accuracy of M-stage diagnosis for lung cancer patients, 10.1002/jmri.21031
  42. Pfannenberg Christina, Aschoff Philip, Schanz Sandra, Eschmann Susanne M., Plathow Christian, Eigentler Thomas K., Garbe Claus, Brechtel Klaus, Vonthein Reinhard, Bares Roland, Claussen Claus D., Schlemmer Heinz P., Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma, 10.1016/j.ejca.2006.11.014
  43. Sakurai Yusuke, Kawai Hisashi, Iwano Shingo, Ito Shinji, Ogawa Hiroshi, Naganawa Shinji, Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer : DWIBS for detecting bone metastases, 10.1111/1754-9485.12020
  44. Schmidt Gerwin P., Schoenberg Stefan O., Schmid Rupert, Stahl Robert, Tiling Reinhold, Becker Christoph R., Reiser Maximilian F., Baur-Melnyk Andrea, Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT, 10.1007/s00330-006-0361-8
  45. Schraml C., Schwenzer N. F., Sperling O., Aschoff P., Lichy M. P., Muller M., Brendle C., Werner M. K., Claussen C. D., Pfannenberg C., Staging of neuroendocrine tumours: comparison of [68Ga]DOTATOC multiphase PET/CT and whole-body MRI, 10.1102/1470-7330.2013.0007
  46. SOHAIB S A, COOK G, ALLEN S D, HUGHES M, EISEN T, GORE M, Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer, 10.1259/bjr/52773262
  47. Takenaka Daisuke, Ohno Yoshiharu, Matsumoto Keiko, Aoyama Nobukazu, Onishi Yumiko, Koyama Hisanobu, Nogami Munenobu, Yoshikawa Takeshi, Matsumoto Sumiaki, Sugimura Kazuro, Detection of bone metastases in non-small cell lung cancer patients: Comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy, 10.1002/jmri.21858
  48. Venkitaraman R, Cook GJR, Dearnaley DP, Parker CC, Khoo V, Eeles R, Huddart RA, Horwich A, Sohaib SA, Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer, 10.1111/j.1754-9485.2009.02070.x
  49. Leboulleux S., Dromain C., Vataire A. L., Malka D., Aupérin A., Lumbroso J., Duvillard P., Elias D., Hartl D. M., De Baere T., Guigay J., Schlumberger M., Ducreux M., Baudin E., Prediction and Diagnosis of Bone Metastases in Well-Differentiated Gastro-Entero-Pancreatic Endocrine Cancer: A Prospective Comparison of Whole Body Magnetic Resonance Imaging and Somatostatin Receptor Scintigraphy, 10.1210/jc.2008-0459
  50. Heusner T.-A., Antoch G., Wittkowski-Sterczewski A., Ladd S., Forsting M., Verhagen R., Scheulen M., Transarterial Hepatic Chemoperfusion of Uveal Melanoma Metastases: Survival and Response to Treatment, 10.1055/s-0031-1281743
  51. Schmidt G. P., Baur-Melnyk A., Haug A., Utzschneider S., Becker C. R., Tiling R., Reiser M. F., Hermann K. A., Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer, 10.1007/s00330-008-1289-y
  52. Roberts Catherine C., Daffner Richard H., Weissman Barbara N., Bancroft Laura, Bennett D. Lee, Blebea Judy S., Bruno Michael A., Fries Ian Blair, Germano Isabelle M., Holly Langston, Jacobson Jon A., Luchs Jonathan S., Morrison William B., Olson Jeffrey J., Payne William K., Resnik Charles S., Schweitzer Mark E., Seeger Leanne L., Taljanovic Mihra, Wise James N., Lutz Stephen T., ACR Appropriateness Criteria® on Metastatic Bone Disease, 10.1016/j.jacr.2010.02.015
  53. Cardoso F., Senkus-Konefka E., Fallowfield L., Costa A., Castiglione M., , Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 10.1093/annonc/mdq160
  54. Khatcheressian James L., Wolff Antonio C., Smith Thomas J., Grunfeld Eva, Muss Hyman B., Vogel Victor G., Halberg Francine, Somerfield Mark R., Davidson Nancy E., American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting, 10.1200/jco.2006.08.8575
  55. Briganti Alberto, Passoni Niccolò, Ferrari Matteo, Capitanio Umberto, Suardi Nazareno, Gallina Andrea, Pozzo Luigi Filippo Da, Picchio Maria, Di Girolamo Valerio, Salonia Andrea, Gianolli Liugi, Messa Cristina, Rigatti Patrizio, Montorsi Francesco, When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool , 10.1016/j.eururo.2009.12.023
  56. Horwich A., Hugosson J., de Reijke T., Wiegel T., Fizazi K., Kataja V., Parker C., Bellmunt J., Berthold D., Bill-Axelson A., Carlsson S., Daugaard G., De Meerleer G., de Reijke T., Dearnaley D., Fizazi K., Fonteyne V., Gillessen S., Heinrich D., Horwich A., Hugosson J., Kataja V., Kwiatkowski M., Nilsson S., Padhani A., Papandreou C., Parker C., Roobol M., Sella A., Valdagni R., Van der Kwast T., Verhagen P., Wiegel T., , Prostate cancer: ESMO Consensus Conference Guidelines 2012, 10.1093/annonc/mds624
  57. Leibovici Dan, Spiess Philippe E., Agarwal Piyush K., Tu Shi-Ming, Pettaway Curtis A., Hitzhusen Kate, Millikan Randall E., Pisters Louis L., Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level, 10.1002/cncr.22372
  58. Kosuda Shigeru, Yoshimura Ichiro, Aizawa Taku, Koizumi Kiyoshi, Akakura Koichiro, Kuyama Junpei, Ichihara Kiyoshi, Yonese Junji, Koizumi Mitsuru, Nakashima Jun, Fujii Hirofumi, Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? : A multicenter retrospective study in Japan, 10.1002/cncr.10340
  59. Erturan Serdar, Yaman Mustafa, Aydın Günay, Uzel Işıl, Müsellim Benan, Kaynak Kamil, The Role of Whole-Body Bone Scanning and Clinical Factors in Detecting Bone Metastases in Patients With Non-small Cell Lung Cancer, 10.1378/chest.127.2.449
  60. Wu Lian-Ming, Gu Hai-Yan, Zheng Jasmine, Xu Xiao, Lin Lin-Hua, Deng Xia, Zhang Wei, Xu Jian-Rong, Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis, 10.1002/jmri.22608
  61. Yang Hui-Lin, Liu Tao, Wang Xi-Ming, Xu Yong, Deng Sheng-Ming, Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy, 10.1007/s00330-011-2221-4
  62. Shen Guohua, Deng Houfu, Hu Shuang, Jia Zhiyun, Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis, 10.1007/s00256-014-1903-9
  63. Houssami N., Costelloe C. M., Imaging bone metastases in breast cancer: evidence on comparative test accuracy, 10.1093/annonc/mdr397
  64. Duo Jian, Han Xiuxin, Zhang Li, Wang Guowen, Ma Yulin, Yang Yun, Comparison of FDG PET/CT and Gadolinium-Enhanced MRI for the Detection of Bone Metastases in Patients With Cancer : A Meta-analysis, 10.1097/rlu.0b013e3182817af3
  65. Khoo Michael M. Y., Tyler Philippa A., Saifuddin Asif, Padhani Anwar R., Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review, 10.1007/s00256-011-1106-6
  66. Schiepers C, Nuyts J, Bormans G et al (1997) Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med 38:1970–1976
  67. Even-Sapir E, Metser U, Flusser G et al (2004) Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 45:272–278
  68. Li Wanhu, Ma Li, Wang Xiaoyue, Sun Jujie, Wang Suzhen, Hu Xudong, 11C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas, 10.1007/s13277-014-2549-x
  69. Positron Emission Tomography, ISBN:9783642211195, 10.1007/978-3-642-21120-1
  70. Ghosh Arundhati, Heston Warren D.W., Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer, 10.1002/jcb.10661
  71. Bacich Dean J., Pinto John T., Tong William P., Heston Warren D.W., Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase, 10.1007/s003350010240
  72. Afshar-Oromieh A., Malcher A., Eder M., Eisenhut M., Linhart H. G., Hadaschik B. A., Holland-Letz T., Giesel F. L., Kratochwil C., Haufe S., Haberkorn U., Zechmann C. M., PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions, 10.1007/s00259-012-2298-2
  73. Luboldt Wolfgang, Küfer Rainer, Blumstein Norbert, Toussaint Todd L., Kluge Alexander, Seemann Marcus D., Luboldt Hans-Joachim, Prostate Carcinoma: Diffusion-weighted Imaging as Potential Alternative to Conventional MR and C-Choline PET/CT for Detection of Bone Metastases, 10.1148/radiol.2492080038
  74. Lecouvet Frédéric E., Vande Berg Bruno C., Malghem Jacques, Omoumi Patrick, Simoni Paolo, Diffusion-weighted MR Imaging: Adjunct or Alternative to T1-weighted MR Imaging for Prostate Carcinoma Bone Metastases?, 10.1148/radiol.2522090263
  75. Mosavi Firas, Johansson Silvia, Sandberg Dan T., Turesson Ingela, Sörensen Jens, Ahlström Håkan, Whole-Body Diffusion-Weighted MRI Compared With 18F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma, 10.2214/ajr.11.8351
  76. Afshar-Oromieh Ali, Avtzi Eleni, Giesel Frederik L., Holland-Letz Tim, Linhart Heinz G., Eder Matthias, Eisenhut Michael, Boxler Silvan, Hadaschik Boris A., Kratochwil Clemens, Weichert Wilko, Kopka Klaus, Debus Jürgen, Haberkorn Uwe, The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer, 10.1007/s00259-014-2949-6
  77. Carrio I (2014) PET/MRI methodology and clinical applications. Springer, Berlin
  78. PET-CT and PET-MRI in Oncology, ISBN:9783642011382, 10.1007/978-3-642-01139-9
  79. ClinicalTrials.gov. In: Health USNIo, ed. (2014)
  80. Sardanelli Francesco, Di Leo Giovanni, Biostatistics for Radiologists, ISBN:9788847011328, 10.1007/978-88-470-1133-5
  81. Walter S.D., Macaskill P., Lord Sarah J., Irwig L., Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect, 10.1002/sim.4444
  82. Higgins Julian P. T., Thompson Simon G., Spiegelhalter David J., A re-evaluation of random-effects meta-analysis, 10.1111/j.1467-985x.2008.00552.x
  83. Lecouvet F.E., Talbot J.N., Messiou C., Bourguet P., Liu Y., de Souza N.M., Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group, 10.1016/j.ejca.2014.07.002
  84. Schmidt Gerwin P., Baur-Melnyk Andrea, Herzog Peter, Schmid Rupert, Tiling Reinhold, Schmidt Michael, Reiser Maximilian F., Schoenberg Stefan O., High-Resolution Whole-Body Magnetic Resonance Image Tumor Staging With the Use of Parallel Imaging Versus Dual-Modality Positron Emission Tomography???Computed Tomography : Experience on a 32-Channel System, 10.1097/01.rli.0000185878.61270.b0